Bijal Modi, M.D.


Private Practice                     NexGen Oncology, Dallas, Texas, August 2008- Present

Private Practice:                   Health & Oncology Service, Porter, Indiana, July 2006–January 2008

Academic:                              Clinical Instructor in Medicine, July 2006–February 2008
University of Illinois at Chicago, Chicago, IL


Fellowship:                            Chief Fellow – Hematology/Oncology, July 2005–June 2006
Hematology/Oncology, July 2003–June 2006
University of Illinois at Chicago Medical Center, Chicago, IL

Residency:                             Internal Medicine, July 2000–June 2003
Thomas Jefferson University Hospital, Philadelphia, PA

Medical School:                    Doctor of Medicine, July 1996–June 2000
University of Medicine and Dentistry of New Jersey (UMDNJ)/
New Jersey Medical School, Newark, NJ
*Seven-Year BA/MD Combined Degree Program

Undergraduate:                     Bachelor of Arts in Biology, July 1993–June 1996
Drew University, Madison, NJ



  • Board Certified – Oncology, October 2006–October 2016        
  • Board Certified – Hematology, October 2006–October 2016    
  • Board Certified – Internal Medicine, October 2003–October 2013        
  • Indiana Medical License, July 2006–Present      
  • Texas Medical License, February 2008-Present



  • Primary Investigator of Phase I Study of Adjuvant Chemotherapy with Cisplatin and Intensity-Modulated Radiation Therapy (IMRT) with Simultaneous Integrated Boost (SIB) for Resected High Risk Head and Neck Cancer




  • Phase I Study of Induction Chemotherapy with Docetaxel, Fluorouracil, and Cisplatin, Followed by Concomitant Cisplatin and Intensity-Modulated Radiation Therapy (IMRT) with a Simultaneous Integrated Boost (SIB) for Advanced Head and Neck Cancer.


  • Primary Investigator of Green Tea Induction of Oral Cytology Markers


  • Mike Yao, MD; Joel Epstein, DDS; Bijal Modi, MD; Kristen Pytynia, MD; AJ Mundt, MD; Lawrence Feldman, MD. Current surgical treatment of squamous cell carcinoma of the head and neck.  Oral Oncology. 2007 Mar; 43(3): 213-223.


  • Bijal Modi, MD; Brian Knab, MD; Lawrence Feldman, MD; Arno Mundt, MD. Current Treatment Options in Head and Neck Cancer.  Expert Opinions in Pharmacotherapy. 2005 Jul; 6(7):1143-1155.
    • Kristine M Mosier, DMD; Wen-Ching Liu, MD; Joseph A Maldigan, MD; Rasesh Shah, Bijal Modi. Lateralization of Cortical Function in Swallowing: A Functional MR Imaging Study.  Journal of Neuroradiology 2000; 20:37-43.


Return to Medical Team List